 Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Principia Biopharma Inc. Principia or the Company NASDAQ: PRNB breached their fiduciary duties in connection with the proposed sale of the Company to Sanofi NASDAQ: SNY. 